Internal Medicine, Hematology & Oncology · Rego Park, NY
NPI
1740281450
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
9785 Queens Blvd
Rego Park, NY, 11374
Phone (718) 261-9100
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
1,283 services
Medicare patients, 2024
252
Average age 76
Drug cost, 2024
$2.4M
912 prescriptions
Company payments, 2025
$1,978
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul B Bader was code 36415 (venipuncture blood collection), 513 times for 168 patients. In total Paul B Bader billed 1,283 services in 17 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 513 | 168 | $8.59 | $4,405 |
| 99214 Office E&M - Established | Office | 294 | 117 | $105.93 | $31K |
| 99213 Office E&M - Established | Office | 234 | 119 | $71.66 | $17K |
| 99232 Hospital E&M - Subsequent | Facility | 59 | 42 | $68.64 | $4,050 |
| 99215 Office E&M - Established | Office | 46 | 29 | $150.06 | $6,903 |
| 99223 Hospital E&M - Initial | Facility | 35 | 33 | $150.72 | $5,275 |
| 99204 Office E&M - New | Office | 35 | 35 | $130.64 | $4,572 |
| 99231 Hospital E&M - Subsequent | Facility | 21 | 20 | $43.00 | $903 |
| 99233 Hospital E&M - Subsequent | Facility | 14 | 11 | $103.29 | $1,446 |
By year: 2022 $71K for 1,189 services; 2023 $72K for 1,174 services; 2024 $77K for 1,283 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 513 | 168 | $8.59 | $4,405 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul B Bader prescribed most often to Medicare patients was Anastrozole, with 102 prescriptions and refills. In total Paul B Bader wrote 912 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 102 | 168 | 22 | $862 |
| Imbruvica Ibrutinib | 68 | 73 | Under 11 | $1.2M |
| Entecavir Generic | 55 | 56 | Under 11 | $15K |
| Hydroxyurea Generic | 52 | 92 | Under 11 | $636 |
| Allopurinol Generic | 37 | 39 | Under 11 | $289 |
| Alendronate Sodium Generic | 36 | 41 | Under 11 | $127 |
| Eliquis Apixaban | 35 | 62 | Under 11 | $31K |
| Lenalidomide Generic | 25 | 25 | Under 11 | $353K |
| Exemestane Generic | 24 | 24 | Under 11 | $1,617 |
| Tamoxifen Citrate Generic | 23 | 25 | Under 11 | $260 |
| Prednisone Generic | 20 | 21 | Under 11 | $44.13 |
| Anagrelide Hcl Generic | 16 | 18 | Under 11 | $2,560 |
| Warfarin Sodium Generic | 16 | 21 | Under 11 | $134 |
| Doxycycline Hyclate Generic | 13 | 13 | Under 11 | $133 |
| Verzenio Abemaciclib | 13 | 13 | Under 11 | $99K |
Brand drugs: 196 claims; generic drugs: 716 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul B Bader $1,978 ($1,978 in general payments such as food, travel and fees) from 28 companies. The largest payer was Novartis Pharmaceuticals Corporation with $234.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 10 | $234 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $192 |
| Abbott Laboratories ABT | 1 | $161 |
| Pfizer Inc. PFE | 7 | $146 |
| GlaxoSmithKline, LLC. GSK | 5 | $121 |
| Janssen Biotech, Inc. JNJ | 4 | $106 |
| Sobi, Inc SOBI.ST | 1 | $99.99 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $98.12 |
| Lilly USA, LLC LLY | 3 | $77.53 |
| Incyte Corporation INCY | 3 | $72.88 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.